Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd. - ROEverified

600276.SS

Price:

$46.85

Market Cap:

$298.86B

Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-10-18

Stock Exchange

SHH

Ticker

600276.SS

The ROE as of October 2026 (TTM) for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) is 12.42%

According to Jiangsu Hengrui Medicine Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 12.42%. This represents a change of 301.93% compared to the average of 3.09% of the last 4 quarters.

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) Historical ROE (quarterly & annually)

How has 600276.SS ROE performed in the past?

The mean historical ROE of Jiangsu Hengrui Medicine Co., Ltd. over the last ten years is 16.51%. The current 12.42% ROE has changed -24.78% with respect to the historical average. Over the past ten years (40 quarters), 600276.SS's ROE was at its highest in in the December 2020 quarter at 6.79%. The ROE was at its lowest in in the December 2021 quarter at 0.92%.

Quarterly (TTM)
Annual

Average

16.51%

Median

17.26%

Minimum

10.33%

Maximum

21.51%

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) ROE by Quarter and Year

Discovering the peaks and valleys of Jiangsu Hengrui Medicine Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 30.93%

Maximum Annual ROE = 21.51%

Minimum Annual Increase = -37.61%

Minimum Annual ROE = 10.33%

Quarterly (TTM)
Annual
YearROEChange
202512.58%-9.59%
202413.92%30.93%
202310.63%2.95%
202210.33%-20.20%
202112.94%-37.61%
202020.75%-3.53%
201921.51%4.35%
201820.61%-1.54%
201720.93%0.15%
201620.90%-4.42%

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) Average ROE

How has 600276.SS ROE performed in the past?

The current ROE of Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

12.38%

5-year avg

12.08%

10-year avg

16.51%

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) ROE vs. Peers

How is 600276.SS’s ROE compared to its peers?

Jiangsu Hengrui Medicine Co., Ltd.’s ROE is greater than Jiangsu Yahong Meditech Co Ltd (-32.29%), less than Sichuan Huiyu Pharmaceutical Co., Ltd. (3.04%), less than BeOne Medicines Ltd. Class A (14.27%), less than Hansoh Pharmaceutical Group Company Limited (18.26%), greater than Shanghai Junshi Biosciences Co., Ltd. (-7.32%), less than Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (2.43%), less than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (39.15%), less than Celltrion, Inc. (9.08%), less than Incyte Corporation (29.70%), less than Shionogi & Co., Ltd. (16.46%),

Build a custom stock screener for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jiangsu Hengrui Medicine Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jiangsu Hengrui Medicine Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Jiangsu Hengrui Medicine Co., Ltd.'s ROE?

How is the ROE calculated for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?

What is the highest ROE for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?

What is the 3-year average ROE for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?

What is the 5-year average ROE for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)?

How does the current ROE for Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) compare to its historical average?